1. Home
  2. VREX vs ASMB Comparison

VREX vs ASMB Comparison

Compare VREX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$12.15

Market Cap

483.7M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$32.62

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
ASMB
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.7M
553.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
VREX
ASMB
Price
$12.15
$32.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$43.40
AVG Volume (30 Days)
356.4K
113.1K
Earning Date
02-05-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$844,600,000.00
$37,191,000.00
Revenue This Year
$4.79
$42.01
Revenue Next Year
$4.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.14
31.30
52 Week Low
$6.76
$7.75
52 Week High
$15.46
$39.71

Technical Indicators

Market Signals
Indicator
VREX
ASMB
Relative Strength Index (RSI) 61.54 40.44
Support Level $11.71 $35.05
Resistance Level $12.00 $36.92
Average True Range (ATR) 0.33 1.93
MACD 0.08 -0.62
Stochastic Oscillator 89.32 4.84

Price Performance

Historical Comparison
VREX
ASMB

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: